A detailed history of Papp L Roy & Associates transactions in Danaher Corp stock. As of the latest transaction made, Papp L Roy & Associates holds 763 shares of DHR stock, worth $175,871. This represents 0.03% of its overall portfolio holdings.

Number of Shares
763
Holding current value
$175,871
% of portfolio
0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$239.25 - $280.76 $182,547 - $214,219
763 New
763 $212,000
Q4 2022

Jan 17, 2023

BUY
$241.42 - $282.29 $182,513 - $213,411
756 New
756 $0
Q2 2022

Aug 02, 2022

SELL
$237.11 - $299.66 $179,255 - $226,542
-756 Closed
0 $0
Q1 2022

May 06, 2022

SELL
$257.27 - $315.76 $771 - $947
-3 Reduced 0.4%
756 $222,000
Q4 2021

Feb 11, 2022

SELL
$292.08 - $329.01 $42,935 - $48,364
-147 Reduced 16.23%
759 $250,000
Q2 2021

Aug 09, 2021

BUY
$225.08 - $271.69 $203,922 - $246,151
906 New
906 $243,000
Q1 2021

May 06, 2021

SELL
$212.38 - $245.9 $260,590 - $301,719
-1,227 Closed
0 $0
Q2 2020

Aug 11, 2020

BUY
$128.7 - $176.83 $157,914 - $216,970
1,227 New
1,227 $217,000
Q1 2020

May 05, 2020

SELL
$121.39 - $169.05 $168,610 - $234,810
-1,389 Closed
0 $0
Q3 2019

Nov 04, 2019

SELL
$135.4 - $146.47 $33,850 - $36,617
-250 Reduced 15.25%
1,389 $201,000
Q2 2019

Aug 14, 2019

BUY
$124.88 - $143.73 $204,678 - $235,573
1,639 New
1,639 $234,000
Q4 2018

Feb 13, 2019

SELL
$94.85 - $109.54 $198,141 - $228,829
-2,089 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$98.13 - $108.9 $204,993 - $227,492
2,089 New
2,089 $227,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Papp L Roy & Associates Portfolio

Follow Papp L Roy & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Papp L Roy & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Papp L Roy & Associates with notifications on news.